ClinicalTrialsFinder

Gastric or Gastroesophageal Junction Adenocarcinoma Clinical Trials in Madison, Wisconsin

1 recruitingMadison, Wisconsin

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Pancreatic Ductal AdenocarcinomaBiliary Tract Cancer (BTC)Gastric or Gastroesophageal Junction Adenocarcinoma
Phanes Therapeutics258 enrolled11 locationsNCT05482893